BMRA today
$1.35+$0.03 (+2.27%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minBullish
5 minConsolidating
Daily trend turns down below $1.45
Key levels
Resistance$1.60
Resistance$1.45
Latest news & SEC filings
EarningsBiomerica Posts $0.37 Per-Share Loss as Quarterly Revenue Slips to $1.265M
All BMRA news →About Biomerica
Biomerica develops, manufactures, and sells diagnostic test kits that examine patient samples such as bodily fluids and stool to help identify diseases, food intolerances, and other conditions. Its offerings include rapid point-of-care tests, a blood test for irritable bowel syndrome, and a test for detecting a common stomach bacterium. These are sold to clinical laboratories, physicians' offices, hospitals, distributors, and over-the-counter channels, and the company also provides contract development and manufacturing services. It operates in Irvine, California, with manufacturing in Mexicali, Mexico, and a European subsidiary, selling worldwide including North America, Asia, Europe, and the Middle East.
Based on the company's 10-K filed Aug 31, 2026.
Nasdaq · Healthcare
BIOMERICA INC (BMRA)
What Is the Price Target for BMRA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is BMRA a Buy or Sell Right Now?
Thesis
- •Revenue growing -16.2% YoY with DECLINING trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BMRA.
Start Free Trial →Is BMRA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$2.89
2
Moat Score
NONE
2/9
Piotroski Score
-12.7
Altman Z-Score
What Is Smart Money Doing with BMRA?
Insider Signal
BUYING
5 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MOATAZEDI DAVID | director | Buy | 10,000 | $16K | Aug 26, 2026 |
| Chin Eric | director | Buy | 6,250 | $10K | Aug 26, 2026 |
| BARBIERI ALLEN | director officer | Buy | 20,000 | $32K | Aug 26, 2026 |
| Irani Zackary S. | director officer | Buy | 31,250 | $50K | Aug 26, 2026 |
| Gary M. Huff | director | Buy | 31,250 | $50K | Aug 20, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BMRA Growth Story
Revenue YoY
-16.2%
3yr Revenue CAGR
-5.9%
EPS Growth YoY
39.81%
FCF Growth YoY
N/A%
Revenue Trend
DECLINING
Dark Pool Trades for BMRA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BMRA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:25:09 | $1.35 | 1,302 | $$2K | SELL |
| 20:54:49 | $1.27 | 2,000 | $$3K | SELL |
| 20:32:57 | $1.40 | 2,068 | $$3K | SELL |
| 15:17:53 | $1.46 | 1,000 | $$1K | SELL |
| 18:44:15 | $1.52 | 1,142 | $$2K | SELL |
5 dark pool trades shown · $$10K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BIOMERICA INC (BMRA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BMRA — frequently asked questions
What is BMRA stock price today?
BIOMERICA INC (BMRA) is at $1.35, up 2.27% (+$0.03) at the Nov 13, 2026 close.
Why is BMRA stock moving today?
Latest BMRA news — Oct 15, 2026: Biomerica Posts $0.37 Per-Share Loss as Quarterly Revenue Slips to $1.265M
Did BMRA beat earnings?
BMRA last reported on Oct 21, 2026: EPS -$0.37 vs -$1.20 expected — a beat of 69.2%.
Does BMRA pay a dividend?
BMRA does not currently pay a dividend.
What are BMRA support and resistance levels?
Resistance: $1.45, $1.60, $1.79.
What are insiders doing with BMRA?
Insider activity: BUYING, 5 buys and 0 sells in the last 90 days.
What is the latest news on BMRA?
Oct 15, 2026: Biomerica Posts $0.37 Per-Share Loss as Quarterly Revenue Slips to $1.265M